Concepedia

Mahfuza Jan

MJ

Statistics

Publications

4

Citations

352

H-Index

4

Active since

2006

Affiliations

University of Pennsylvania(Current)

Mahfuza Jan is an author at University of Pennsylvania specializing in cell signaling, drug discovery, and jak-stat signaling pathway.

Top concepts

Publications per year

2006–2012

4

Publications

4

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan et al. · Blood · 2007 · 251 citations · Full text

A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-<i>a</i>]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779

Benjamin J. Dugan, Diane E. Gingrich, Eugen F. Mesaros et al. · Journal of Medicinal Chemistry · 2012 · 62 citations · Full text

CEP-701 Is a JAK2 Inhibitor Which Attenuates JAK2/STAT5 Signaling Pathway and the Proliferation of Primary Cells from Patients with Myeloproliferative Disorders.

Paweł Dobrzański, Elizabeth O. Hexner, Cynthia Serdikoff et al. · Blood · 2006 · 20 citations

Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases

Craig A. Zificsak, Diane E. Gingrich, Henry J. Breslin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

, , +13

1–4 of 4